The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Michael T. Halpern

Exponent

Inc., Alexandria

Virginia 22314

USA

[email]@exponent.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Exponent, Inc., Alexandria, Virginia 22314, USA. 2002 - 2006
  • Exponent, Inc., 1800 Diagonal Rd., Suite 355, USA. 2003 - 2005
  • Exponent, Alexandria, USA. 2004

References

  1. Resource utilization and costs of age-related macular degeneration. Halpern, M.T., Schmier, J.K., Covert, D., Venkataraman, K. Health. Care. Financ. Rev (2006) [Pubmed]
  2. Meta-analysis of bacterial resistance to macrolides. Halpern, M.T., Schmier, J.K., Snyder, L.M., Asche, C., Sarocco, P.W., Lavin, B., Nieman, R., Mandell, L.A. J. Antimicrob. Chemother. (2005) [Pubmed]
  3. Costs and outcomes of extended-release vs. immediate-release clarithromycin for lower respiratory tract infections. Halpern, M.T., Cifaldi, M.A., Schmier, J.K. COPD (2005) [Pubmed]
  4. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Halpern, M.T., Schmier, J.K., Van Kerkhove, M.D., Watkins, M., Kalberg, C.J. Ann. Allergy Asthma Immunol. (2004) [Pubmed]
  5. Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity. Halpern, M.T., Schmier, J.K., Richner, R., Guo, C., Togias, A. J. Asthma (2004) [Pubmed]
  6. Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents. Halpern, M.T., Lacey, M., Clark, M.A., Valentin, M.A. BMC. Cardiovasc. Disord (2004) [Pubmed]
  7. The workplace impact of acute exacerbations of chronic bronchitis (AECB); A literature review. Halpern, M.T., Polzin, J., Higashi, M.K., Bakst, A. COPD (2004) [Pubmed]
  8. Economic analysis of the Confronting COPD survey: methodology. Halpern, M.T., Musin, A., Sondhi, S. Respir. Med (2003) [Pubmed]
  9. The burden of COPD in the U.S.A.: results from the Confronting COPD survey. Halpern, M.T., Stanford, R.H., Borker, R. Respir. Med (2003) [Pubmed]
  10. Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis. Halpern, M.T., Khan, Z.M., Stanford, R.H., Spayde, K.M., Golubiewski, M. J. Fam. Pract (2003) [Pubmed]
  11. The economic impact of acute exacerbations of chronic bronchitis in the United States and Canada: a literature review. Halpern, M.T., Higashi, M.K., Bakst, A.W., Schmier, J.K. J. Manag. Care. Pharm (2003) [Pubmed]
  12. Pharmacoeconomic studies and the pharmaceutical industry: bias in which direction?. Halpern, M. Expert. Rev. Pharmacoecon. Outcomes. Res (2003) [Pubmed]
  13. Relationship of AcrySof acrylic and PhacoFlex silicone intraocular lenses to visual acuity and posterior capsule opacification. Halpern, M.T., Covert, D., Battista, C., Weinstein, A.J., Levinson, R.D., Yan, L. J. Cataract. Refract. Surg (2002) [Pubmed]
  14. Cost-effectiveness of gemifloxacin: results from the GLOBE study. Halpern, M.T., Palmer, C.S., Zodet, M., Kirsch, J. Am. J. Health. Syst. Pharm (2002) [Pubmed]
  15. Costs and outcomes of early versus delayed migraine treatment with sumatriptan. Halpern, M.T., Lipton, R.B., Cady, R.K., Kwong, W.J., Marlo, K.O., Batenhorst, A.S. Headache (2002) [Pubmed]
 
WikiGenes - Universities